ADMA Biologics Inc (ADMA)
20.26
-0.02
(-0.10%)
USD |
NASDAQ |
Mar 28, 16:00
20.14
-0.12
(-0.59%)
After-Hours: 06:20
ADMA Biologics Profit Margin (Quarterly): 95.19% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Emergent BioSolutions Inc | -16.53% |
| TG Therapeutics Inc | 21.57% |
| Cara Therapeutics Inc | -527.8% |
| Ocular Therapeutix Inc | -283.3% |
| Ocugen Inc | -1.82K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 93.41% |
| Return on Assets | 51.06% |
| Return on Invested Capital | 60.85% |
| Gross Profit Margin (Quarterly) | 53.88% |
| Operating Margin (Quarterly) | 32.60% |
| Return on Net Operating Assets | 69.74% |